Implanted Medical Device

DEVICE5 trials

Conditions

Breast NeoplasmIntrahepatic CholangiocarcinomaLesionLiver and Intrahepatic Bile Duct CarcinomaLiver and Intrahepatic Bile Duct DisorderPositive Axillary Lymph NodeStage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7

Early Phase 1

SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer

CompletedNCT03411070

Jonsson Comprehensive Cancer CenterPositive Axillary Lymph Node, Stage 0 Breast Cancer AJCC v6 and v7, Stage IA Breast Cancer AJCC v7 +9

Start: 2019-04-07End: 2021-12-06Updated: 2023-01-17

Phase 2

mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Active, not recruitingNCT04251715

OHSU Knight Cancer InstituteLiver and Intrahepatic Bile Duct Carcinoma, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 +3

Start: 2021-04-28End: 2025-11-30Updated: 2025-04-18

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

RecruitingNCT04891289

Memorial Sloan Kettering Cancer CenterIntrahepatic Cholangiocarcinoma

Start: 2021-05-07End: 2027-05-01Target: 164Updated: 2026-04-01

Phase 3

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

Active, not recruitingNCT03214510

M.D. Anderson Cancer CenterLiver and Intrahepatic Bile Duct Disorder

Start: 2017-10-04End: 2026-07-31Updated: 2026-03-05

Unknown Phase

Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery

CompletedNCT03202472

Jonsson Comprehensive Cancer CenterBreast Neoplasm, Lesion

Start: 2017-08-03End: 2019-02-01Updated: 2020-07-24

International Journal of Molecular Sciences2024-08-243 citations

A phase II trial of induction systemic mFOLFIRINOX followed by hepatic arterial infusion of floxuridine and dexamethasone given concurrently with systemic mFOLFIRI as a first-line therapy in patients with unresectable liver-dominant intrahepatic cholangiocarcinoma (HELIX-1).

Journal of Clinical Oncology2024-01-204 citations

ASO Author Reflections: Usage of Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Annals of Surgical Oncology2022-03-09

HELIX-ICC: An-open label phase II trial of induction systemic mFOLFIRINOX followed by concurrent hepatic arterial infusion of floxuridine and systemic mFOLFIRI for unresectable intrahepatic cholangiocarcinoma.

Journal of Clinical Oncology2022-01-19

SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study.

2021-10-1524 citations

Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.

2021-03-29112 citations

Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery.

2019-01-2833 citations